secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORDSON CORP (NDSN)
CIK:        0000072331
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0000072331-25-000053
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M
--------------------------------------------------------------------------------

- Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.
- Reported EPS $1.97 vs $2.05 prior year; adjusted EPS $2.42 (+3% YoY) above guidance midpoint.
- Advanced Technology Solutions organic sales +18% YoY; Medical & Fluid Solutions +20% (incl. Atrion).
- Q3 guidance: sales $710-$750M, adjusted EPS $2.55-$2.75 per diluted share.
- Backlog grew ~5% sequentially; company repurchased $85M in shares during the quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/0000072331-25-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/ndsn-20250528.htm
  HTML page:      https://secwatch.observer/filing/0000072331-25-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer